4/A//SEC Filing
Renninger Robert 4/A
Accession 0001415889-25-007858
CIK 0001620463other
Filed
Mar 11, 8:00 PM ET
Accepted
Mar 12, 5:20 PM ET
Size
6.1 KB
Accession
0001415889-25-007858
Insider Transaction Report
Form 4/AAmended
Renninger Robert
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-03-03+73,350→ 73,350 totalExercise: $0.38Exp: 2035-03-02→ Common Stock (73,350 underlying)
Footnotes (1)
- [F1]One fourth (1/4th) of shares subject to the option shall be scheduled to vest on the one (1)-year anniversary of the grant date, and one thirty-sixth (1/36th) of the remaining Shares subject to the Option each month thereafter on the same day of the month as the grant date subject to the optionee continuing to be a Service Provider (as defined in the Issuer's 2020 Equity Incentive Plan) through the applicable vesting dates.
Documents
Issuer
Athira Pharma, Inc.
CIK 0001620463
Entity typeother
Related Parties
1- filerCIK 0002037968
Filing Metadata
- Form type
- 4/A
- Filed
- Mar 11, 8:00 PM ET
- Accepted
- Mar 12, 5:20 PM ET
- Size
- 6.1 KB